Amy E Rothberg, MD, DABOM
Professor of Internal Medicine
Adjunct Clinical Associate Professor of Nutritional Sciences
[email protected]

Available to mentor

Amy E Rothberg, MD, DABOM
Clinical Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Amy E. Rothberg, MD, DABOM is Clinical Professor of Medicine in the Division of Metabolism, Endocrinology and Diabetes and Professor of Nutritional Sciences in the School of Public Health at the University of Michigan. She is the Director of the University of Michigan Weight Management Program, a 2-year intensive behavioral and lifestyle program onto which there is a multifaceted research program in which patients undergo extensive baseline and interval phenotyping to identify the factors that predict successful and cost-effective long-term weight loss. Her primary research is funded by the NIH/NIDDK. Her work encompasses three major research foci: The first is on the impact of the interventions on insulin secretion, insulin action, long-term glycemia, the development of complications and comorbidities, health-related quality-of-life, and cost. The second is on the behavioral and biological determinants of weight loss and weight loss maintenance. The third is scalability of her program through telehealth and the internet and the impact on the processes and outcomes of care.

    Qualifications
    • Residency
      University of Michigan, Internal Medicine
    Center Memberships
    • Center Member
      Caswell Diabetes Institute
    Research Overview

    - Determining factors that predict successful and cost-effective long-term weight loss
    - Assessing the neurobiopsychosocial adaptations that occur with weight loss
    - Evaluating implementation of a model of intensive behavioral therapy from sub-speciality care into primary care
    - Impact of weight loss on health related quality of life
    - Effects of intensive lifestyle intervention on reproductive, maternal and fetal outcomes

    Recent Publications See All Publications
    • Journal Article
      Remission of type 2 diabetes: always more questions, but enough answers for action.
      Rothberg A, Lean M, Laferrère B. Diabetologia, 2024 Apr; 67 (4): 602 - 610. DOI:10.1007/s00125-023-06069-1
      PMID: 38189935
    • Additional Scholarship
      CANVAS8 article on “Why Eli Lilly’s Zepbound entices the weight-loss market”
      Tenti S. 2024 Mar;
    • Additional Scholarship
      Medscape article regarding Handling Weight Loss Drug Shortage
      Rothberg A. 2024 Mar;
    • Additional Scholarship
      Medscape article regarding Handling Weight Loss Drug Shortage
      Rothberg A. 2024 Mar;
    • Additional Scholarship
      quoted in Fortune magazine on “Weight-loss drugs like Wegovy are meant for long-term use”,
      Aleccia J. 2024 Mar;
    • Additional Scholarship
      Interviewed by MedPage Today, Endocrine Society interview request
      Fiore K. 2024 Feb 22;
    • Journal Article
      How to assess kidney outcomes in obese people with substantial weight loss: the case of GLP1- and dual-receptor agonists.
      Rothberg AE, Herman WH. Nephrol Dial Transplant, 2024 Jan 31; DOI:10.1093/ndt/gfae024
      PMID: 38299776
    • Presentation
      Shaking Up Nutrition
      2024 Jan 17;